Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy |
---|---|
Disease/Condition | Breast Cancer,Women`s Health,Oncology (Medical/Hematologic),Carcinoma,Neoplasms |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Jesus Anampa Mesias, MD |
Contact Name | Amanda Erakky |
Contact Email | aerakky@montefiore.org |
IRB/Protocol Number | 2018-9832 |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Medical and Hematologic Oncology - Breast |